On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…
On Apr. 19, 2021, the NIH announced that it was funding a large, randomized, placebo-controlled Phase 3 clinical…
On Apr. 19, 2021, scientists at the Texas A&M University Global Health Research Complex (GHRC) announced they had…
On Apr. 19, 2021, CytoDyn announced it had submitted the manufacturing section (CMC) of the application for an…
On Apr. 16, 2021, the FDA approved Bristol-Myers Squibb’ s Opdivo (nivolumab), in combination with certain types of…
On Apr. 16, 2021, the FDA revoked the emergency use authorization (EUA) that allowed for Eli Lilly’s investigational…
On Apr. 15. 2021, a team of researchers led by the University of Minnesota Medical School announced they…
On Apr. 15, 2021, Merck and Ridgeback Biotherapeutics, and Ridgeback Biotherapeutics announced that based on a planned interim…
On Apr. 15, 2021, Merck announced the discontinuation of development of MK-7110 (formerly known as CD24Fc) for the…
On Apr. 15, 2021, the World Health Organization (WHO) reported that the world was still failing to develop…
On Apr. 15, 2021, researchers at the University of Oxford reported that the risk of the rare blood…
On Apr. 15, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had had established…
On Apr. 15, 2021, The National Institute of Allergy and Infectious Diseases (NIAID) announced that the fourth iteration…
On Apr. 15, 2021, the National Institutes of Health announced that the experimental antiviral drug MK-4482 significantly decreased…
On Apr. 15, 2021, Inovio Pharmaceuticals announced the results of a study focusing on the human immune responses…
On Apr. 15, 2021, CytoDyn announced it had executed an exclusive supply and distribution agreement with Chiral Pharma…
On Apr. 14, 2021, following concern raised around thrombotic events, AstraZeneca offered its reassurance on the safety of…
On Apr. 14, 2021, researchers running the Com-Cov study, launched in February to investigate alternating doses of the…
On Apr. 14, 2021, Moderna announced that results from a preclinical study of the Company’s COVID-19 variant-specific vaccine…
On Apr. 14, 2021, Novavax announced its participation in an expanded investigator-initiated Phase 2 clinical trial called Comparing…
On Apr. 14, 2021, the Mayo Clinic announced a new technology platform initiative to deliver the next generation…
On Apr. 14, 2021, National Institutes of Health researchers reported that a study which compared to newborns conceived…
On Apr. 13, 2020, the Allen Discovery Center for Human Brain Evolution announced a study that traced developmental…
On Apr. 13, 2021, a clinical trial testing the safety and efficacy of an investigational monoclonal antibody for…
On Apr. 13, 2021, a large study of children has uncovered evidence that behavioral problems in children who…
On Apr. 13, 2021, Cardinal Health was awarded a $57.8 million contract, including options that if exercised by…
As of Apr. 12, 2021, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine were…
On Apr. 13, 2021, the FDA and CDC announced that they were are reviewing data involving six reported…
On Apr. 13, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
On Apr. 13, 2021, Moderna announced that new results from a preclinical study of the Company’s COVID-19 variant-specific…